NCI Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural researchThe group replaced the NCI Board of Scientific Advisors February 06, 2026Vol.52 No.05By Claire Marie Porter
Capitol Hill After a brief government shutdown, FY26 funding bill is signed into lawNIH gets $415M raise, NCI gets $128M more, CDMRP funding largely restored February 06, 2026Vol.52 No.05By Jacquelyn Cobb
Guest Editorial The National Highway Traffic Safety Administration has a profound, albeit not immediately obvious, impact on cancer February 06, 2026Vol.52 No.05By Ken Kobayashi and Joan H. Schiller
Cancer Policy “Basic Experimental Studies Involving Humans” no longer classified as clinical trials at NIH in an effort to reduce administrative burden February 06, 2026Vol.52 No.05By Jacquelyn Cobb
Cancer Policy FDA debuts precheck manufacturing program to boost domestic drug development February 06, 2026Vol.52 No.05By Claire Marie Porter
In Brief Alex Khariton named COO and SVP for cancer services at Fox Chase February 06, 2026Vol.52 No.05
In Brief George Coukos launches Ludwig Laboratory for Cell Therapy at Weill Cornell February 06, 2026Vol.52 No.05
In Brief MSK launches MSK Care Partners to expand access to cancer care February 06, 2026Vol.52 No.05
